ivabradine has been researched along with Adverse Drug Event in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brunetti, ND; Correale, M; Di Biase, M; Monaco, I; Zicchino, S | 1 |
Asselbergs, FW; Bots, SH; Day, D; den Ruijter, HM; Eikendal, ALM; Groepenhoff, F; Miller, VM; Regitz-Zagrosek, V; Rochon, PA; Tannenbaum, C | 1 |
Kaehler, J; Koester, R; Meinertz, T | 1 |
1 review(s) available for ivabradine and Adverse Drug Event
Article | Year |
---|---|
Adverse Drug Reactions to Guideline-Recommended HeartĀ FailureĀ Drugs in Women: A Systematic Review of the Literature.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Drug-Related Side Effects and Adverse Reactions; Female; Heart Failure; Humans; Ivabradine; Male; Mineralocorticoid Receptor Antagonists; Mortality; Practice Guidelines as Topic; Research Design; Research Report; Sex Distribution; Sex Factors; Stroke Volume | 2019 |
1 trial(s) available for ivabradine and Adverse Drug Event
Article | Year |
---|---|
Ivabradine for the treatment of stable angina pectoris in octogenarians.
Topics: Aged, 80 and over; Angina Pectoris; Benzazepines; Bradycardia; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Ivabradine; Male | 2011 |
1 other study(ies) available for ivabradine and Adverse Drug Event
Article | Year |
---|---|
Angiotensin-converting enzyme inhibitors, angiotensin II receptors antagonists, beta-blockers and ivabradine as supportive therapy in pulmonary hypertension: Drug safety and tolerability.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypertension, Pulmonary; Ivabradine; Male; Middle Aged; Patient Readmission | 2017 |